Page 839«..1020..838839840841..850860..»

Category Archives: Transhuman News

Hungary requires booksellers to cover up LGBTQ+ themed books in stores – Gay Times Magazine

Posted: August 9, 2021 at 9:04 am

The bill has widely been compared to Russias gay propaganda law, which was passed in 2013, that bans disseminating propaganda on nontraditional sexual relations among Russians.

Since being approved in June, the law has come under fire by LGBTQ+ activists and the European Commission.

MEPs called the legislation a clear breach of the EUs values, principles and law and has since urged the European Commission to pursue a legal case against Orbns government.

459 Members of the European Parliament (MEPs) voted in favour of the resolution, with 147 against and 58 abstaining in Strasbourg. If the case is brought to the European Court of Justice, the country could face financial penalties.

Ursula Von der Leyen, the president of the European Commission, called the law disgraceful in a statement.

This law uses the protection of children, to which we are all committed, as an excuse to severely discriminate against people because of their sexual orientation. This law is disgraceful.

Orbn has since doubled down on the hateful law stating that it was made to protect children. He also said that education surrounding sexuality should be in the hands of parents.

LGBTQ+ activists visit kindergartens and schools and conduct sexual education classes. They want to do this here in Hungary as well, he stated in aFacebook videoon Wednesday (21 July).

Related: Hungarys prime minister Viktor Orbn to hold referendum on anti-LGBTQ+ law.

Follow this link:
Hungary requires booksellers to cover up LGBTQ+ themed books in stores - Gay Times Magazine

Posted in Censorship | Comments Off on Hungary requires booksellers to cover up LGBTQ+ themed books in stores – Gay Times Magazine

Whole-genome sequencing of Schistosoma mansoni reveals extensive diversity with limited selection despite mass drug administration – Nature.com

Posted: at 9:00 am

Hotez, P. J. et al. The Global Burden of Disease Study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl. Trop. Dis. 8, e2865 (2014).

World Health Organization. Prevention and Control of Schistosomiasis and Soil-transmitted Helminthiasis: Report of a WHO Expert Committee (World Health Organization, 2002).

Montresor, A., Engels, D., Ramsan, M., Foum, A. & Savioli, L. Field test of the dose pole for praziquantel in Zanzibar. Trans. R. Soc. Trop. Med. Hyg. 96, 323324 (2002).

CAS PubMed Article PubMed Central Google Scholar

World Health Organization. Helminth Control in School-aged Children: A Guide for Managers of Control Programmes (World Health Organisation, 2006).

World Health Organization. Schistosomiasis and soil-transmitted helminthiases: numbers of people treated in 2019. Wkly. Epidemiol. Rec. 95, 629640 (2020).

Google Scholar

Kabatereine, N. B. et al. Impact of a national helminth control programme on infection and morbidity in Ugandan schoolchildren. Bull. World Health Organ 85, 9199 (2007).

PubMed PubMed Central Article Google Scholar

Bronzan, R. N. et al. Impact of community-based integrated mass drug administration on schistosomiasis and soil-transmitted helminth prevalence in Togo. PLoS Negl. Trop. Dis. 12, e0006551 (2018).

PubMed PubMed Central Article Google Scholar

Deol, A. K. et al. Schistosomiasisassessing progress toward the 2020 and 2025 global goals. N. Engl. J. Med. 381, 25192528 (2019).

World Health Organization. Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation. https://apps.who.int/iris/bitstream/handle/10665/338712/WHO-HTM-NTD-2012.5-eng.pdf (2012).

World Health Organization. A road map for neglected tropical diseases 20212030. https://www.who.int/neglected_diseases/Ending-the-neglect-to-attain-the-SDGsNTD-Roadmap.pdf (2020).

Mutuku, M. W. et al. A search for snail-related answers to explain differences in response of Schistosoma mansoni to praziquantel treatment among responding and persistent hotspot villages along the Kenyan shore of Lake Victoria. Am. J. Tropical Med. Hyg. 101, 6577 (2019).

CAS Article Google Scholar

Assar, R. K. et al. Characteristics of persistent hotspots of Schistosoma mansoni in western Cte dIvoire. Parasit. Vectors 13, 337 (2020).

PubMed PubMed Central Article CAS Google Scholar

Kittur, N. et al. Persistent hotspots in schistosomiasis consortium for operational research and evaluation studies for gaining and sustaining control of schistosomiasis after four years of mass drug administration of praziquantel. Am. J. Trop. Med. Hyg. 101, 617627 (2019).

PubMed PubMed Central Article Google Scholar

Wiegand, R. E. et al. A persistent hotspot of Schistosoma mansoni infection in a five-year randomized trial of praziquantel preventative chemotherapy strategies. J. Infect. Dis. 216, 14251433 (2017).

PubMed PubMed Central Article Google Scholar

Hedtke, S. M. et al. Genomic epidemiology in filarial nematodes: transforming the basis for elimination program decisions. Front. Genet. 10, 1282 (2019).

CAS PubMed Article PubMed Central Google Scholar

Doyle, S. R. & Cotton, J. A. Genome-wide approaches to investigate anthelmintic resistance. Trends Parasitol. 35, 289301 (2019).

CAS PubMed Article PubMed Central Google Scholar

Crellen, T. et al. Whole genome resequencing of the human parasite Schistosoma mansoni reveals population history and effects of selection. Sci. Rep. 6, 113 (2016).

Article CAS Google Scholar

Gower, C. M. et al. Population genetic structure of Schistosoma mansoni and Schistosoma haematobium from across six sub-Saharan African countries: implications for epidemiology, evolution and control. Acta Trop. 128, 261274 (2013).

PubMed Article PubMed Central Google Scholar

Standley, C., Kabatereine, N., Lange, C., Lwambo, N. & Stothard, J. Molecular epidemiology and phylogeography of Schistosoma mansoni around Lake Victoria. Parasitology 137, 19371949 (2010).

CAS PubMed Article PubMed Central Google Scholar

Faust, C. L. et al. Two-year longitudinal survey reveals high genetic diversity of Schistosoma mansoni with adult worms surviving praziquantel treatment at the start of mass drug administration in Uganda. Parasit. Vectors 12, 607 (2019).

PubMed PubMed Central Article Google Scholar

Stothard, J. R. et al. Molecular epidemiology of Schistosoma mansoni in Uganda: DNA barcoding reveals substantial genetic diversity within Lake Albert and Lake Victoria populations. Parasitology 136, 18131824 (2009).

CAS PubMed Article PubMed Central Google Scholar

Norton, A. J. et al. Genetic consequences of mass human chemotherapy for Schistosoma mansoni: population structure pre- and post-praziquantel treatment in Tanzania. Am. J. Trop. Med. Hyg. 83, 951957 (2010).

PubMed PubMed Central Article Google Scholar

Blanton, R. E. et al. Schistosoma mansoni population structure and persistence after praziquantel treatment in two villages of Bahia, Brazil. Int. J. Parasitol. 41, 10931099 (2011).

PubMed PubMed Central Article Google Scholar

Gower, C. M. et al. Phenotypic and genotypic monitoring of Schistosoma mansoni in Tanzanian schoolchildren five years into a preventative chemotherapy national control programme. Parasit. Vectors 10, 593 (2017).

PubMed PubMed Central Article CAS Google Scholar

Chevalier, F. D. et al. Oxamniquine resistance alleles are widespread in Old World Schistosoma mansoni and predate drug deployment. PLoS Pathog. 15, e1007881 (2019).

CAS PubMed PubMed Central Article Google Scholar

Platt, R. N. et al. Ancient hybridization and adaptive introgression of an invadolysin gene in schistosome parasites. Mol. Biol. Evol. 36, 21272142 (2019).

PubMed PubMed Central Article CAS Google Scholar

Shortt, J. A. et al. Population genomic analyses of schistosome parasites highlight critical challenges facing endgame elimination efforts. Sci. Rep. 11, 6884 (2021).

ADS CAS PubMed PubMed Central Article Google Scholar

Truscott, J. E. et al. A comparison of two mathematical models of the impact of mass drug administration on the transmission and control of schistosomiasis. Epidemics 18, 2937 (2017).

CAS PubMed PubMed Central Article Google Scholar

Bouzat, J. L. Conservation genetics of population bottlenecks: the role of chance, selection, and history. Conserv. Genet. 11, 463478 (2010).

Article Google Scholar

Andrews, P. Praziquantel: mechanisms of anti-schistosomal activity. Pharmacol. Ther. 29, 129156 (1985).

CAS PubMed Article PubMed Central Google Scholar

Cioli, D. & Pica-Mattoccia, L. Praziquantel. Parasitol. Res. 90, S3S9 (2003).

Caffrey, C. R. Schistosomiasis and its treatment. Future Med. Chem. 7, 675676 (2015).

CAS PubMed Article PubMed Central Google Scholar

Kaplan, R. M. & Vidyashankar, A. N. An inconvenient truth: global worming and anthelmintic resistance. Vet. Parasitol. 186, 7078 (2012).

PubMed Article PubMed Central Google Scholar

Rose, H. et al. Widespread anthelmintic resistance in European farmed ruminants: a systematic review. Vet. Rec. 176, 546 (2015).

CAS PubMed Article PubMed Central Google Scholar

Schwab, A. E., Boakye, D. A., Kyelem, D. & Prichard, R. K. Detection of benzimidazole resistance-associated mutations in the filarial nematode Wuchereria bancrofti and evidence for selection by albendazole and ivermectin combination treatment. Am. J. Trop. Med. Hyg. 73, 234238 (2005).

CAS PubMed Article PubMed Central Google Scholar

Fallon, P. G. & Doenhoff, M. J. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am. J. Trop. Med. Hyg. 51, 8388 (1994).

CAS PubMed Article Google Scholar

Couto, F. F. B. et al. Schistosoma mansoni: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails. Mem. Inst. Oswaldo Cruz 106, 153157 (2011).

CAS PubMed Article PubMed Central Google Scholar

Mwangi, I. N. et al. Praziquantel sensitivity of Kenyan Schistosoma mansoni isolates and the generation of a laboratory strain with reduced susceptibility to the drug. Int. J. Parasitol. Drugs Drug Resist. 4, 296300 (2014).

PubMed PubMed Central Article Google Scholar

Lamberton, P. H. L., Faust, C. L. & Webster, J. P. Praziquantel decreases fecundity in Schistosoma mansoni adult worms that survive treatment: evidence from a laboratory life-history trade-offs selection study. Infect. Dis. Poverty 6, 110 (2017).

PubMed PubMed Central Article Google Scholar

Stelma, F. F. et al. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am. J. Trop. Med. Hyg. 53, 167170 (1995).

CAS PubMed Article Google Scholar

Melman, S. D. et al. Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl. Trop. Dis. 3, e504 (2009).

PubMed PubMed Central Article CAS Google Scholar

Crellen, T. et al. Reduced efficacy of praziquantel against Schistosoma mansoni is associated with multiple rounds of mass drug administration. Clin. Infect. Dis. 63, 11511159 (2016).

CAS PubMed PubMed Central Google Scholar

King, C. H., Muchiri, E. M. & Ouma, J. H. Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya. Emerg. Infect. Dis. 6, 585594 (2000).

CAS PubMed PubMed Central Article Google Scholar

Gryseels, B. et al. Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Trop. Med. Int. Health 6, 864873 (2001).

CAS PubMed Article Google Scholar

Fenwick, A. & Webster, J. P. Schistosomiasis: challenges for control, treatment and drug resistance. Curr. Opin. Infect. Dis. 19, 577582 (2006).

PubMed Article Google Scholar

Albonico, M. et al. Monitoring the efficacy of drugs for neglected tropical diseases controlled by preventive chemotherapy. J. Glob. Antimicrob. Resist 3, 229236 (2015).

CAS PubMed PubMed Central Article Google Scholar

Fukushige, M., Chase-Topping, M., Woolhouse, M. E. J. & Mutapi, F. Efficacy of praziquantel has been maintained over four decades (from 1977 to 2018): a systematic review and meta-analysis of factors influence its efficacy. PLoS Negl. Trop. Dis. 15, e0009189 (2021).

CAS PubMed PubMed Central Article Google Scholar

Hodgkinson, J. E. et al. Refugia and anthelmintic resistance: concepts and challenges. Int. J. Parasitol. Drugs Drug Resist. 10, 5157 (2019).

PubMed PubMed Central Article Google Scholar

Walker, M. et al. New approaches to measuring anthelminthic drug efficacy: parasitological responses of childhood schistosome infections to treatment with praziquantel. Parasit. Vectors 9, 41 (2016).

PubMed PubMed Central Article CAS Google Scholar

Kittur, N. et al. Defining persistent hotspots: areas that fail to decrease meaningfully in prevalence after multiple years of mass drug administration with praziquantel for control of schistosomiasis. Am. J. Trop. Med. Hyg. 97, 18101817 (2017).

PubMed PubMed Central Article Google Scholar

Levecke, B. et al. Evaluation of the therapeutic efficacy of praziquantel against schistosomes in seven countries with ongoing large-scale deworming programs. Int. J. Parasitol. Drugs Drug Resist. 14, 183187 (2020).

CAS PubMed PubMed Central Article Google Scholar

Nei, M., Maruyama, T. & Chakraborty, R. The bottleneck effect and genetic variability in populations. Evolution 29, 110 (1975).

PubMed Article PubMed Central Google Scholar

Gattepaille, L. M., Jakobsson, M. & Blum, M. G. B. Inferring population size changes with sequence and SNP data: lessons from human bottlenecks. Heredity 110, 409419 (2013).

CAS PubMed PubMed Central Article Google Scholar

Kohn, A. B., Anderson, P. A. V., Roberts-Misterly, J. M. & Greenberg, R. M. Schistosome Calcium Channel Subunits: unusual modulatory effects and potential role in the action of the antischistosomal drug praziquantel. J. Biol. Chem. 276, 3687336876 (2001).

Read more here:
Whole-genome sequencing of Schistosoma mansoni reveals extensive diversity with limited selection despite mass drug administration - Nature.com

Posted in Genome | Comments Off on Whole-genome sequencing of Schistosoma mansoni reveals extensive diversity with limited selection despite mass drug administration – Nature.com

The Secret History of Corn And Its Jumping Genes Revealed in Its Genome – SciTechDaily

Posted: at 9:00 am

This ear of corn was grown and analyzed by Nobel Prize-winning Cold Spring Harbor Laboratory (CSHL) geneticist Barbara McClintock decades ago. From her observations, she surmised that parts of the corn genome jumped from one location to another, generating a great deal of genetic diversityin this case many different colors of kernels. CSHL researchers expanded on her work by sequencing the genomes of multiple corn strains, mapping even the mobile portions of the genome. Credit: CSHL Library & Archives

Humans adapt through language and culture, passing down knowledge from one generation to the next. Corn plants cant talk, so they solve the problem of adaptability in a different way: they use jumping genes to shuffle the genetic deck over generations. Jumping genesnow called transposonswere discovered by Nobel Prize-winning Cold Spring Harbor Laboratory (CSHL) geneticistBarbara McClintockin the 1940s. Decades later, CSHL scientists are still expanding on her work.Doreen Ware, a CSHL adjunct professor and research scientist at the US Department of Agriculture (USDA) and her colleagues, published genome sequences from 26 different strains of corn in the journalScience. The genomes describe a large portion of the genetic diversity found inmodern corn plants, including transposons and genes that regulate desired crop traits.

CSHL Adjunct Professor and USDA research scientist Doreen Ware in a cornfield at CSHLs Uplands Farm. Credit: Ware lab/CSHL

Corn has been bred to grow in various climates of the world, from temperate to tropical, and from highlands to lowlands. Ware says:

Humans have brains. Our main adaptive component is our ability to transfer culture and knowledge, right? And thats how we deal with our environment. A plants strategy is to have a fluid genome. They have a very intimate relationship with these transposons, where they use them to bring in new genetic diversity so that they can deal with these events because they cant run away. Theyre not going to go into the house, and theyre not going to move water to them.

Ware and her colleagues, including CSHL Professor & HHMI InvestigatorRob Martienssenand CSHL ProfessorW. Richard McCombie, mapped thefirst corn genomein 2009; they have been filling in gaps ever since. Like a continental landscape, genomic maps have areas that are full of features (like well-mapped cities), whereas others are more like deserts (vast and uncharted). With recent techniques, the team of scientists charted difficult stretches of the genome, even the deserts. These complete genomes allow researchers to locate and study bothimportant crop genesand the nearby regions that regulate their use. Ware notes, we had little access to the regulatory architecture of corn before.

The new collection reveals how the corn genome was shuffled over time. Ware says:

These genomes provide us a footprint of that life history. Different strains have experienced different environments. For example, some came from tropical environments, others experienced particular diseases, and all those selective pressures leave a footprint of that history.

Corn is one of the most common agricultural staples in the world, with more than366 million metric tonsgrown in the US from 2018 to 2019. Equipped with more detailed maps of the corn genome, scientists have a head start in developing crops for a rapidly changing climate. Ware explains, The Midwest is not going to have the same temperature profile twenty years from now. The genomes provide broader insights into corn genetics, and this, in turn, can be used to start optimizing corn to grow in future environments.

Reference: De novo assembly, annotation, and comparative analysis of 26 diverse maize genomes by Matthew B. Hufford, Arun S. Seetharam, Margaret R. Woodhouse, Kapeel M. Chougule, Shujun Ou, Jianing Liu, William A. Ricci, Tingting Guo, Andrew Olson, Yinjie Qiu, Rafael Della Coletta, Silas Tittes, Asher I. Hudson, Alexandre P. Marand, Sharon Wei, Zhenyuan Lu, Bo Wang, Marcela K. Tello-Ruiz, Rebecca D. Piri, Na Wang, Dong won Kim, Yibing Zeng, Christine H. OConnor, Xianran Li, Amanda M. Gilbert, Erin Baggs, Ksenia V. Krasileva, John L. Portwood II, Ethalinda K. S. Cannon, Carson M. Andorf, Nancy Manchanda, Samantha J. Snodgrass, David E. Hufnagel, Qiuhan Jiang, Sarah Pedersen, Michael L. Syring, David A. Kudrna, Victor Llaca, Kevin Fengler, Robert J. Schmitz, Jeffrey Ross-Ibarra, Jianming Yu, Jonathan I. Gent, Candice N. Hirsch, Doreen Ware and R. Kelly Dawe, 6 August 2021, Science.DOI: 10.1126/science.abg5289

The project was a multi-institutional effort with researchers at CSHL, USDA, University of Georgia, Iowa State University, University of Minnesota, and Corteva Agriscience. The new collection of genomes is available online athttp://maize-pangenome.gramene.org/.

Go here to read the rest:
The Secret History of Corn And Its Jumping Genes Revealed in Its Genome - SciTechDaily

Posted in Genome | Comments Off on The Secret History of Corn And Its Jumping Genes Revealed in Its Genome – SciTechDaily

MIT Researchers Devised a Way To Program Memories Into Bacterial Cells by Rewriting Their DNA – SciTechDaily

Posted: at 9:00 am

MIT researchers have devised a way to program memories into bacterial cells by rewriting their DNA more efficiently. Credit: MIT News, iStockphoto

Technique for editing bacterial genomes can record interactions between cells, may offer a way to edit genes in the human microbiome.

Biological engineers at MIT have devised a new way to efficiently edit bacterial genomes and program memories into bacterial cells by rewriting their DNA. Using this approach, various forms of spatial and temporal information can be permanently stored for generations and retrieved by sequencing the cells DNA.

The new DNA writing technique, which the researchers call HiSCRIBE, is much more efficient than previously developed systems for editing DNA in bacteria, which had a success rate of only about 1 in 10,000 cells per generation. In a new study, the researchers demonstrated that this approach could be used for storing memory of cellular interactions or spatial location.

This technique could also make it possible to selectively edit, activate, or silence genes in certain species of bacteria living in a natural community such as the human microbiome, the researchers say.

With this new DNA writing system, we can precisely and efficiently edit bacterial genomes without the need for any form of selection, within complex bacterial ecosystems, says Fahim Farzadfard, a former MIT postdoc and the lead author of the paper. This enables us to perform genome editing and DNA writing outside of laboratory settings, whether to engineer bacteria, optimize traits of interest in situ, or study evolutionary dynamics and interactions in the bacterial populations.

Timothy Lu, an MIT associate professor of electrical engineering and computer science and of biological engineering, is the senior author of the study, which was published on August 5, 2021, in Cell Systems. Nava Gharaei, a former graduate student at Harvard University, and Robert Citorik, a former MIT graduate student, are also authors of the study.

For several years, Lus lab has been working on ways to use DNA to store information such as memory of cellular events. In 2014, he and Farzadfard developed a way to employ bacteria as a genomic tape recorder, engineering E. coli to store long-term memories of events such as a chemical exposure.

To achieve that, the researchers engineered the cells to produce a reverse transcriptase enzyme called retron, which produces a single-stranded DNA (ssDNA) when expressed in the cells, and a recombinase enzyme, which can insert (write) a specific sequence of single-stranded DNA into a targeted site in the genome. This DNA is produced only when activated by the presence of a predetermined molecule or another type of input, such as light. After the DNA is produced, the recombinase inserts the DNA into a preprogrammed site, which can be anywhere in the genome.

That technique, which the researchers called SCRIBE, had a relatively low writing efficiency. In each generation, out of 10,000 E. coli cells, only one would acquire the new DNA that the researchers tried to incorporate into the cells. This is in part because the E. coli have cellular mechanisms that prevent single-stranded DNA from being accumulated and integrated into their genomes.

In the new study, the researchers tried to boost the efficiency of the process by eliminating some of E. colis defense mechanisms against single-stranded DNA. First, they disabled enzymes called exonucleases, which break down single-stranded DNA. They also knocked out genes involved in a system called mismatch repair, which normally prevents integration of single-stranded DNA into the genome.

With those modifications, the researchers were able to achieve near-universal incorporation of the genetic changes that they tried to introduce, creating an unparalleled and efficient way for editing bacterial genomes without the need for selection.

Because of that improvement, we were able to do some applications that we were not able to do with the previous generation of SCRIBE or with other DNA writing technologies, Farzadfard says.

In their 2014 study, the researchers showed that they could use SCRIBE to record the duration and intensity of exposure to a specific molecule. With their new HiSCRIBE system, they can trace those kinds of exposures as well as additional types of events, such as interactions between cells.

As one example, the researchers showed that they could track a process called bacterial conjugation, during which bacteria exchange pieces of DNA. By integrating a DNA barcode into each cells genome, which can then be exchanged with other cells, the researchers can determine which cells have interacted with each other by sequencing their DNA to see which barcodes they carry.

This kind of mapping could help researchers study how bacteria communicate with each other within aggregates such as biofilms. If a similar approach could be deployed in mammalian cells, it could someday be used to map interactions between other types of cells such as neurons, Farzadfard says. Viruses that can cross neural synapses could be programmed to carry DNA barcodes that researchers could use to trace connections between neurons, offering a new way to help map the brains connectome.

We are using DNA as the mechanism to record spatial information about the interaction of bacterial cells, and maybe in the future, neurons that have been tagged, Farzadfard says.

The researchers also showed that they could use this technique to specifically edit the genome of one species of bacteria within a community of many species. In this case, they introduced the gene for an enzyme that breaks down galactose into E. coli cells growing in culture with several other species of bacteria.

This kind of species-selective editing could offer a novel way to make antibiotic-resistant bacteria more susceptible to existing drugs by silencing their resistance genes, the researchers say. However, such treatments would likely require several years more years of research to develop, they say.

The researchers also showed that they could use this technique to engineer a synthetic ecosystem made of bacteria and bacteriophages that can continuously rewrite certain segments of their genome and evolve autonomously with a rate higher than would be possible by natural evolution. In this case, they were able to optimize the cells ability to consume lactose consumption.

This approach could be used for evolutionary engineering of cellular traits, or in experimental evolution studies by allowing you to replay the tape of evolution over and over, Farzadfard says.

Reference: Efficient retroelement-mediated DNA writing in bacteria by Fahim Farzadfard, Nava Gharaei, Robert J. Citorik and Timothy K. Lu, 5 August 2021, Cell Systems.DOI: 10.1016/j.cels.2021.07.001

The research was funded by the National Institutes of Health, the Office of Naval Research, the National Science Foundation, the Defense Advanced Research Projects Agency, the MIT Center for Microbiome Informatics and Therapeutics, the NSF Expeditions in Computing Program Award, and the Schmidt Science Fellows Program.

Read more here:
MIT Researchers Devised a Way To Program Memories Into Bacterial Cells by Rewriting Their DNA - SciTechDaily

Posted in Genome | Comments Off on MIT Researchers Devised a Way To Program Memories Into Bacterial Cells by Rewriting Their DNA – SciTechDaily

Levantines and Arabians have different origins, Middle East genomic study finds – Haaretz

Posted: at 9:00 am

Apparently, it is so: Anatomically modern humans have been leaving Africa for almost a quarter million years, but they all went extinct until an exit around 50,000 to 60,000 years ago. A new study of genomes in the Middle East shores up this hypothesis, finding no trace of the early humans in any of the genomes tested.

One of the routes out of Africa for hominins going back 2 million years, and later, for humans too, was the Levant, Iraq and Arabia. Indeed, researchers have found evidence of human and hominin exits in various places, including Israel and Saudi Arabia: stuff like the odd bone or a batch of stone tools.

The prevailing belief is that the groups taking part in the earliest migrations went extinct (though not before encountering other hominins in Eurasia). Then about 50,000 to 60,000 years ago, anatomical humans left Africa and survived. They met and mixed with Neanderthals and heavens knows who else, and begat modern humanity.

This belief that the early exiters did not survive is now bolstered by an international team led by Mohamed Almarri of the Wellcome Genome Campus in Britain. In their study, published in Cell, they looked at the genomic history of the Middle East and concluded that present-day populations in Arabia, the Levant including Israel, and Iraq have no signals from those early modern humans.

We used a new whole genome sequencing technology to study human populations from the Levant [Lebanon, Syria, Jordan, Israel and the West Bank], Iraq and Arabia, and we reconstruct the population history of the region from over 125,000 years ago up to the last millennium, Almarri says. We show how changes in lifestyle and climate have affected the demography of human populations in the region.

How does one test latter-day DNA for signals older than 60,000 years? By the density of mutations, he explains: The more mutations there are, the older the segments will be.

Thats a generalization; some genetic sequences are more evolutionarily conserved than others. If you check the sequence for the protein ubiquitin, it will be the same from a human to a tree frog and obviously, for earlier humans. But if a given segment has a ton of mutations (that didnt kill the bearer), we may assume its old.

Also, obviously modern humans didnt descend from newly-created beings who sprang up some 60,000 years ago; we will have some very, very ancient DNA. But, Almarri explains, when a population expands, the migrants are a tiny percent of the original population. The same would have applied to the African exit.

And indeed, genomic studies of todays non-African populations show a genetic bottleneck around that time, Almarri says. Non-Africans all descend from exiters around 50,000 to 60,000 years ago and are much less genetically diverse than sub-Saharan Africans, who suffered no bottleneck.

The Neanderthals and the Levantines

Moving on, Levantines and Iraqis share the same Neanderthal signals as Eurasians, the team found. Arabians on the other hand have less Neanderthal DNA.

The reason apparently lies in origins. Levantines have more ancestry (than Arabians) from Europe and Anatolia. The Arabians have more ancestry (than Levantines) from Africans, who didnt mix with Neanderthals, and from Natufians, who were the prehistoric inhabitants of the Levant, including Israel.

The Natufians were prehistoric peoples living about 11,000 to 16,000 years ago in what is today Israel, Jordan and Lebanon. Its possible that they also reached Arabia, but their remains havent been found.

Also, present-day Africans are believed to have a contribution from Neanderthals after all, a very small one, conferred by early humans who trekked in reverse from Europe back to Africa after mixing with Neanderthals.

Anyway, the Arabians of today apparently didnt arise from early Levantine farmers but from Natufian hunter-gatherers who preceded these farmers and Africans, the study shows. Nor do the findings support the theory that Levantine farmers later replaced the indigenous Arabian population.

It bears stressing that human fossil remains are incredibly rare; from the deep prehistoric past Saudi Arabia has so far produced one finger bone from 85,000 years ago, but it has also produced tools that may have been special to humans (as opposed to other hominins) from 125,000 years ago. In Israel there are a lot more very ancient human remains, starting with the 200,000-year-old jawbone found in Misliya, and there are more when you get to the Natufian period but theyre still very rare.

Desertification and population collapse

Another difference the genomic analysis indicated relates to the Neolithic Revolution the invention of agriculture.

But here it bears stressing that the Middle East, Arabia and North Africa werent always baking-hot deserts. Sometimes, depending on planetary orbital cycles, they greened. Hippos and crocodiles cavorted in lakes and rivers, and hominins and later, modern humans could comfortably roam.

When the Neolithic Revolution the gradual transition from a life of hunting and gathering to agriculture and animal husbandry began over 10,000 years ago, Arabia and the Sahara were in such a lush period. The Arabian Desert as we know it today, the biggest sand desert in the world, didnt exist. It began to form sometime between 6,000 to 8,000 years ago. (That might help explain the paucity of prehistoric human remains.)

The Neolithic Revolution drove a massive population increase in the Levant and Iraq, but not in Arabia. The team even postulates that the small population groups of ancient Arabians may have perpetuated or descended from the local epipaleolithic hunting-gathering groups.

But as the Arabian Desert was forming, about 6,000 years ago its population imploded. The same would happen in the Levant about 4,200 years ago, commensurate with an intense aridification event.

We find that prehistorical aridification and desertification events have resulted in population crashes a few thousands of years ago, the team says a warning for today, with all due respect to desalination technology.

Say it in Semitic

Current-day peoples the team studied in the Levant, Arabia and Iraq turned out to form distinct core clusters: Populations from the Levant and Iraq (Lebanese, Syrians, Jordanians, Israeli Druze, and Iraqi Arabs) clustered together. The Iraqi Kurds clustered with central Iranians.

The Arabians (Emiratis, Saudis, Yemenis and Omanis) clustered with Bedouin who are from Israel, too. These samples were collected by the Human Genome Diversity Project and were sequenced by us, Almarri notes.

Fascinatingly, both the Iraqi Kurds and Iranians, who clustered together, speak Indo-Iranian languages Kurdish isnt Arabic or Semitic, its Indo-Iranian. All the other people sampled in the study speak Arabic, a Semitic language.

The clustering patterns we find reflect the historical ancestries present in modern-day populations. In the Levant [and Iraqi Arabs], all the populations we tested have higher Anatolian-like ancestry, which is much rarer in Arabia. Arabian populations in contrast have higher Natufian-like ancestry, Almarri says.

Apropos language, the team also suggests that a Bronze Age population in the Levant (meaning from about 5,000 years ago) plausibly was responsible for spreading Semitic languages to Arabia and East Africa.

A glass of milk and thou

Marc Haber of the University of Birmingham notes that the study detected positive selection for lactose digestion the ability to drink and eat dairy products without experiencing socially repulsive and painful consequences.

In the last 8,000 years this variant increased to a frequency of 50 percent in Arabians, coinciding with the transition from a hunter-gatherer to herder-gatherer lifestyle. This variant is much rarer in the Levant, and almost absent outside the region, Haber says.

For this study, researchers at the Wellcome Sanger Institute collected 137 samples from people in eight Middle Eastern populations for sequencing. The genomic data was then analyzed at Wellcome Sanger and the University of Birmingham to look for variations in the genomes that could help map out human evolution from 100,000 years ago to today, the researchers explain.

It bears adding that apparently the domestication of the sheep, goats and cows wasnt driven by a desire to exploit their milk but to eat the whole animal, instead of hunting for toothsome herbivores.

What have we learned? That we thrived after the advent of agriculture but were brought low by climate change. That we did not thrive in the Arabian Desert but did when it was wetter and greener. Did we do that?

We did not the greening and aridification of North Africa and Arabia were due to planetary cycles, not human impact. Today Arabia contains the largest sand desert in the world (though not the largest desert), but by the next time the cycle swings and the area should, theoretically, turn green again, it may not happen, and thats on us.

Read more:
Levantines and Arabians have different origins, Middle East genomic study finds - Haaretz

Posted in Genome | Comments Off on Levantines and Arabians have different origins, Middle East genomic study finds – Haaretz

Genome Editing Market Research Report 2021 Elaborate Analysis With Growth Forecast To 2027 OriGene, Thermo Fisher Scientific, NEB, Integrated DNA…

Posted: at 9:00 am

Genome editing, genome engineering or gene editing is a type of genetic engineering in which DNA is inserted, deleted, changed or replaced in the genome of a living organism. The genome editing market is expected to grow shortly because an important element driving the market is the increase in financial resources.

Governments in many regions are increasing funding and grants to support genome editing research. Because of the advantages of genome editing, various governments are promoting public and commercial research, as well as academic institutes, to increase research efforts in the field of genome editing and genetic engineering.

The updated report on the Genome Editing market gives a precise analysis of the value chain assessment for the review period of 2021 to 2027. The research includes an exhaustive evaluation of the administration of the key market companies and their revenue-generating business strategies adopted by them to drive sustainable business. The Healthcare industry report further enlists the market shortcomings, stability, growth drivers, restraining factors, opportunities for the projected timeframe.

Get Sample Report with Latest Industry Trends Analysis: http://www.a2zmarketresearch.com/sample?reportId=327395

The top companies in this report include:

OriGene, Thermo Fisher Scientific, NEB, Integrated DNA Technologies, Inc, Lonza Group Ltd., Sangamo, GenScript, Transposagen, IDT, Horizon

The Global Genome Editing market is expected to register a notable market expansion of 14.8% during the review period owing to the largest market value in 2019. The market study provides a measure of the effectiveness of the product, real-time Genome Editing market scenario, along custom ease. The study further offers market analysis, strategies and planning, R & D landscape, target audience management, market potential, due diligence, and competitive landscape.

Market Segmentation

Segment By Type

CRISPRTALENZFNAntisenseOther Technologies

Segment By Application

Cell Line EngineeringAnimal Genetic EngineeringPlant Genetic EngineeringOther Applications

Scope of the report

A thorough analysis of statistics about the current as well as emerging trends offers clarity regarding the Genome Editing market dynamics. The report includes Porters Five Forces to analyze the prominence of various features such as the understanding of both the suppliers and customers, risks posed by various agents, the strength of competition, and promising emerging businesspersons to understand a valuable resource. Also, the report spans the Genome Editing research data of various companies, benefits, gross margin, strategic decisions of the worldwide market, and more through tables, charts, and infographics.

The Genome Editing report highlights an all-inclusive assessment of the revenue generated by the various segments across different regions for the forecast period, 2021 to 2027. To leverage business owners, gain a thorough understanding of the current momentum, the Genome Editing research taps hard to find data on aspects including but not limited to demand and supply, distribution channel, and technology upgrades. Principally, the determination of strict government policies and regulations and government initiatives building the growth of the Genome Editing market offers knowledge of what is in store for the business owners in the upcoming years.

Request For Customized Report: http://www.a2zmarketresearch.com/enquiry?reportId=327395

Geographic analysis

The global Genome Editing market has been spread across North America, Europe, Asia-Pacific, the Middle East and Africa, and the rest of the world.

COVID-19 Impact Analysis

The pandemic of COVID-19 has emerged in lockdown across regions, line limitations, and breakdown of transportation organizations. Furthermore, the financial vulnerability Genome Editing Market is a lot higher than past flare-ups like the extreme intense respiratory condition (SARS), avian influenza, pig influenza, bird influenza, and Ebola, inferable from the rising number of contaminated individuals and the vulnerability about the finish of the crisis. With the rapid rising cases, the worldwide Genome Editing refreshments market is getting influenced from multiple points of view.

The accessibility of the labor force is by all accounts disturbing the inventory network of the worldwide Genome Editing drinks market as the lockdown and the spread of the infection are pushing individuals to remain inside. The presentation of the Genome Editing makers and the transportation of the products are associated.

If the assembling movement is stopped, transportation and, likewise, the store network additionally stops. The stacking and dumping of the items, i.e., crude materials and results (fixings), which require a ton of labor, is likewise vigorously affected because of the pandemic. From the assembling plant entryway to the stockroom or from the distribution center to the end clients, i.e., application ventures, the whole Genome Editing inventory network is seriously compromised because of the episode.

The research provides answers to the following key questions:

Buy Exclusive Report: http://www.a2zmarketresearch.com/buy?reportId=327395

Contact Us:

Roger Smith

1887 WHITNEY MESA DR HENDERSON, NV 89014

[emailprotected]

+1 775 237 4147

See the original post here:
Genome Editing Market Research Report 2021 Elaborate Analysis With Growth Forecast To 2027 OriGene, Thermo Fisher Scientific, NEB, Integrated DNA...

Posted in Genome | Comments Off on Genome Editing Market Research Report 2021 Elaborate Analysis With Growth Forecast To 2027 OriGene, Thermo Fisher Scientific, NEB, Integrated DNA…

The Extinct Species Within – The Scientist

Posted: at 9:00 am

Nestled in the middle of the Himalayas is the Tibetan plateaua large, flat, largely grassy expanse with an average elevation of over 4,500 meters. At such heights, the air is thin, and because of the surrounding mountains, the region receives little rain. Its a cold, harsh environmentone that many animals simply arent cut out for.

Homo sapiensmanaged to settle in this unforgiving landscape around 30,000 to 40,000 years ago, and around 10,000 years ago, they brought their dogs. While that might suggest our species is especially rugged or adaptable, we now know that neither the people nor their pets toughed it out aloneboth cribbed DNA notes from other species in order to adapt. Either before, during, or shortly after their migration to the plateau, H. sapiensgot friendly with Denisovans, while their domesticated dogs interbred with Tibetan wolves. And from those hybridizations, both picked up adaptive variants of the EPAS1 gene, which encode version of the protein that help their bodies, and especially their blood, cope with lower levels of oxygen. You have the exact same [phenomenon] between dogs and wolves as you have between humans and Denisovans, explains Rasmus Nielsen, a geneticist with the University of California, Berkeley. Its so cool.

But it turns out that, for the canines, thats not the whole story. Nielsen and his colleagues discovered that before wolves passed EPAS1 along to dogs, the wild canids obtained the helpful EPAS1variant by breeding with another canine speciesone that, to this day, remains unknown.

Researchers refer to these extinct species, whose genes linger in the genomes of living animals, as ghost lineages, and we now know theyre everywhere in the tree of lifethey simply remained obscured until recently, when advances in sequencing technology and genomic analyses began to reveal them.

The more genomes that have been sequenced from the more different lineages and species and places in the world, the more we see that when things interact with each other in space and can interbreed, they do.

Beth Shapiro, University of California, Santa Cruz

For example, while scientists have known for more than a decade that modern humans carry sequences from ancient hybridizations with Neanderthals and Denisovans, more recent analyses suggest there are other ancestors haunting our genomes. Discovering when and where species of humans interbred with and interacted with each other will tell the hidden stories of our past and help us understand why H. sapiens is the only hominin species left alive today. And were just one caseThere are instances where these kinds of events are even more profound, even more dramatic, in other species, says Sriram Sankararaman, a computational biologist at the University of California, Los Angeles, who has studied ancient hybridizations in humans.

The more genomes that are sequenced, the more researchers are finding that these ancient genetic whispers have many secrets to tell about all kinds of animals.

Wolves are not alone, of course, in their penchant for mating with more distant kin. Thanks to similar genetic echoes of hybridization, scientists know brown bears cozied up to cave bears before the latter went extinct (and they continue to romp with polar bears), elephant species interbred frequently back in the time of mammoths, and cats apparently fornicate with other felines at almost any opportunity. The more genomes that have been sequenced from the more different lineages and species and places in the world, the more we see that when things interact with each other in space and can interbreed, they do, says Beth Shapiro, an evolutionary biologist at the University of California, Santa Cruz, who worked with Nielsen on the Tibetan dogs paper.

Now, scientists are realizing those matings arent just fruitful in the sense that they produce surviving offspring. I think theres a growing sense that this could be a way for a population or a species to quickly adapt as it moves into new environments, says Sankararaman. In fact, this kind of adaptation via hybridization, or whats often referred to as adaptive introgression, seems to happen all the time.

The idea that hybridization plays a significant role in evolution is old hat to botanists, but fairly new for zoologistsfrom within the last five years, says Nielsen. The prevailing view, thanks to influential 20th century biologists such as Ernst Mayr, had been that the comingling of distant relatives was rare and of little importance, especially in mammals.

One of the earliest pieces of evidence for adaptive introgression in mammals came from a 2015 study on domesticated pigs (Sus scrofa domesticus) where a ghost Sus lineage was uncovered. Researchers in China were looking for genomic signatures of adaptation to northern latitudes (and, therefore, genes that may confer cold tolerance) in 11 domesticated breeds when they spotted something strange: A 14-megabase region of the X chromosome that not only differed between northern and southern breeds, it appeared that the northern version emerged some 3.5 million years before the entire Sus scrofaspecies split from from other wild pigs.

A 2015 study in Nature Genetics found that pig breeds from northern China, such as the Meishan pig above, possess DNA from an unknown, extinct Susspecies.

When the team created an evolutionary tree for that chunk of the genome, which included their domesticated pig breeds as well as Chinese and European wild boars (S. scrofa) and four other pigs (genus Sus), they found that the southern breeds clustered with the other Sus species, as one might expect, but the northern breeds formed their own distinctive group with European wild boarsa pattern which suggested they both received the 14-Mb chunk from an unknown and likely extinct pig species. Two years later, the same research group found another genethis time, one that may have been involved in domesticationthat also appears to have entered the domestic pig genome through hybridization with another, as-yet-unidentified Sus species.

Whether people intentionally bred their pigs with other swine species or just happened to select for genes from a natural hybridization event is unknown. Either way, these findings are far from the only documented examples of adaptive introgression. In addition to the EPAS1 examples in humans and dogs, genetic research has confirmed that western European house mice (Mus musculus domesticus) obtained a gene conferring resistance to the rodenticide warfarin from the Algerian mouse (Mus spretus) and gulf killifish (Fundulus grandis) can tolerate heavily polluted waters thanks to genes garnered from Atlantic killifish (F. heteroclitus). These and numerous other instances of adaptive introgression from recent years have bolstered the idea that hybridization is a key mechanism for evolution. Its a new way of thinking about evolution, that really species . . . [are] not isolatedtheyre connected to other species, says Nielsen, and when the environment changes, they can pick up DNA to adapt to new environmental conditions.

If thats broadly true, then looking for ghost sequences could be a way to find useful genes, argue Yunnan Universitys Yan Li and the Kunming Institute of Zoologys Dong-Dong Wu in a July Journal of Genetics and Genomicsreview paper. [T]he search for a genetic legacy of unknown species, particularly adaptive introgressed variants, in the genomes of extant livestock and crops will provide new sources of genetic variation for breeding and therefore help solve a pressing issue for humans, they write.

Nielsen agrees with that premise. Those genes that have been jumping from one species to another species and so on, theyre probably the important genes for that environment, he says, and could be used to grant species desirable traits. Humans have long been trying to capture such traits through hybridization. Some 10,000 years ago, people bred Chinese pigs with European ones, passing along key fertility and immunity traits to the latter. Similarly, research has revealed that domesticated cattle in China were bred with yak and banteng, a species of cattle endemic to Southeast Asia, to help them survive high altitudes and tropical environments, respectively.

Modern genetic science enables a more surgical approach: using gene editing to insert specific genes or variants into animals genomes, rather than producing hybrid offspring with a mishmash of genes from different species and using selective breeding to fine-tune the traits of future generations. This type of gene editing is already being done with plants and is being explored in livestock, so in the future, ghost DNA could be targeted to confer desired traits to the plants and animals we cultivate.

Not all of these spectral sequences are adaptive. Still, even genomic ghosts that have persisted through chance could prove invaluable to researchers, as they may reveal novel insights about evolution and the ecology of bygone ecosystems.

Studies on ancient introgression in felines have noted that interspecies dalliances have a marked impact on our ability to accurately reconstruct evolutionary relationships, so theyre important for evolutionary biologists to consider when reconstructing the tree of life. These sequences arent mere noise, thoughon the contrary, analyzing them is like another way of looking into the fossil record, says Shapiro, but rather than having fossils that are actual bones, we have tiny little snippets of the genomes of these extinct species that tell us that they existed.

Take those pigs, for example. The identified ancient genes suggest that the origin story of domesticated pigs is more complex than previously thought and point to gaps in our knowledge of the ecosystems where domestication occurred. After all, the genomic findings imply that there are two species of pigs weve never sequenced that were common enough in the past to leave a genetic footprint on our swine.

The investigation of genomic ghosts for ecological and evolutionary purposes is still in its infancy, as cutting-edge statistical methods for detecting ancient introgression have only recently been developed. Plus, these methods have mostly been designed to delve deeper into the hybridizations that occurred in hominins, says Martin Kuhlwilm, an evolutionary biologist at the University of Vienna. Because of that, they may not work as well in other species.

For instance, many of these methods require full genomes from the ancient relatives in questionsomething we have for Neanderthals and Denisovans, but which are rare for other extinct animals. Still, the field of ancient DNA is exploding, so its not hard to imagine a future where scientists can employ tools developed for human ancestry studies on any animal species, yielding information that could help explain why they, and not their ghost kin, are the ones still around today.

Analytical tools arent the only challenge to this kind of work. For some species, especially endangered ones, simply obtaining specimens can be onerous or expensive. And when the science doesnt directly teach us more about human health, Kuhlwilm says, its difficult to convince someone to pay for all of that.

Kuhlwilm maintains that such research is worth the investment, because beyond being cool, the data they provide is invaluable and often impossible to obtain through other methods. His work on chimpanzees and bonobos (Pan troglodytesand P. paniscus), our closest living relatives, is a perfect example. These animals are similar in many ways, but they differ markedly in behaviorwith bonobos often noted for being less aggressive and more sexual than chimpsand have subtler variations in their physiology and ecology. Many researchers are interested in understanding the origin of these differencesunfortunately, the fossil record for great apes is particularly spotty, so there is little to draw on when seeking answers about their evolutionary history.

Bonobos received DNA from a now-extinct ape approximately 500,000 years ago.

So Kuhlwilm and his colleagues looked to the apes genomes for clues instead. Introgression analyses run on 69 chimpanzee and bonobo genomes revealed that the two species had hybridized in the past, but even more surprisingly, 0.94.2 percent of the bonobo genome was made up of DNA from an otherwise unknown ape. These segments contained genes related to immunity, physiology, and behavior, all of which suggests some of the notable differences between bonobos and chimpanzees may stem in part from the formers hybridization with another species.

So far, we dont know much about this ghost ape that likely shaped bonobos into the gentler of our great ape cousins. The researchers were able to reconstruct an estimated 4.8 percent of its genome from their samples, but widespread sequencing of bonobos could reveal much more, allowing researchers to dig into questions about the apes physiologyanswers that could provide novel insights.

Indeed, Sankararaman notes that with enough data, ghost sequences could bring the past to life in an unprecedented way. We might be able to use [reconstructed archaic] genomes to say something about the phenotypes of these extinct populations, he says. From such reconstructions, researchers could garner even more information about extinct animals biology and ecology, as some things are just easier to glean from a visual.

Such inferences are still a long way off. Connecting mutations to anatomy or behaviors is an incredibly hard problem, he notes, and even in humans, our ability to go from genome to a phenotype or trait is pretty limited. Still, such work would be really exciting, he says.

Unfortunately, research into the ghosts in animal genomes is racing against the clock, says Kuhlwilm, because it relies on sequencing many genomes from extant species. I think the main obstacle right now is the speed at which these species disappear. Finding enough genomes from wild individuals and getting them sequenced is becoming a challenge . . . and that is very sad.

All people alive today carry ghost sequences from other human species. According to a Science Advances paper published July 16 that Shapiro coauthored, about half of the human genome can contain sequences from introgression events, during which DNA flowed in by mating with Neanderthals, Denisovans, and potentially other as yet uncharacterized hominin specieseven though each individuals proportion of DNA from other species is only about 2 to 4 percent.

Shapiro and her colleagues largely focused their study on the parts of the genome without these introgressions. Their reasoning, says Shapiro, is that those segments make us, well, human. Its probably in there, in that little, tiny portion of the genome where nobody has any archaic DNA . . . where we really need to look hard for those genes that make us unique, she says.

Shapiro explains that even if you sequenced the genome of every person on the planet today and pieced together all the ancient bits of DNA that exist within them, you wouldnt be able construct a complete Neanderthal or Denisovan genome. Parts of their genomes simply dont exist in modern humans.

Its probable that some, if not most, of these missing pieces dropped out of the genomes of modern humans by chance, but Shapiro says that for others, you just couldnt have the Neanderthal or Denisovan version and still be a human, so those segments of archaic DNA were eliminated from modern humans through negative selection.

Ed Green, a biomolecular engineer at University of California, Santa Cruz, Shapiro, and their graduate student at the time, Nathan Schaefer (now a postdoc at University of California, San Francisco), went in search of those incompatible regions.

First, they developed a method for detecting archaic introgression that they called SARGE because its based on whats known as an ancestral recombination graph (ARG). Essentially, Green says, it creates an evolutionary tree for every locus, which gives it the power needed to separate archaic introgression from genes shared with other species because of ancestry, as well as the ability to detect what Green and his colleagues refer to as archaic deserts that genetically separate us from our kin.

Using SARGE, the team examined 279 modern human genomes from the Simons Genome Diversity Project, which sampled from populations all over the world, as well as two Neanderthal genomes and one Denisovan genome. The analysis suggested at least one major wave of breeding between Neanderthals and modern humans and several smaller mixing events with Denisovans. The algorithm also detected other archaic genesgenetic variation retained from the common ancestors that gave rise to us and our closest kin (what geneticists refer to as incomplete lineage sorting). A mere 7 percent of our genomes lacked any trace of archaic DNA.

Within these archaic deserts, the team zeroed in on regions that also had high-frequency mutations totally unique to modern humans, reasoning that these changes occurred after Homo sapiens split from our kin and then spread through much of the human population. Theyre where any H. sapiens-specific novelty lies, says Green.

The team estimates that such human-specific regions make up roughly 1.5 percent of our genomes. Per base, these regions have more genes, coding regions of genes, and regulatory element binding sites than other parts of the genomeanother clue that theyre especially important to us. In addition, that 1.5 percent turned out to be highly enriched in genes that have to do with nervous system function, says Green.

Other groups have reached similar conclusions, especially with regard to the uniqueness of human nervous system genes, notes University of Vienna evolutionary biologist Martin Kuhlwilm, who did not participate in the study, but the new work provides higher resolution than past studies. Thats the most valuable contribution of their new method, he says, adding that with their methods, they can basically go down to a handful of genes, which can be the target of further studies to uncover the functional consequences of human-specific variants.

He adds that he hopes to see this kind of detailed work occur in nonhuman animals, especially primates. For instance, analyzing what the human-specific parts of the genome look like in chimpanzees could reveal whether those regions are broadly species-defining, or if theyre only special in us. Such analyses could further refine what makes us really human, he says.

The rest is here:
The Extinct Species Within - The Scientist

Posted in Genome | Comments Off on The Extinct Species Within – The Scientist

Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non-muscle-invasive Bladder Cancer – DocWire News

Posted: at 9:00 am

Eur Urol Oncol. 2021 Aug 2:S2588-9311(21)00120-6. doi: 10.1016/j.euo.2021.07.001. Online ahead of print.

ABSTRACT

BACKGROUND: Non-muscle-invasive bladder cancer (NMIBC) is characterized by frequent recurrences and a risk of progression in stage and grade. Increased knowledge of underlying biological mechanisms is needed.

OBJECTIVE: To identify single nucleotide polymorphisms (SNPs) associated with recurrence-free (RFS) and progression-free (PFS) survival in NMIBC.

DESIGN, SETTING, AND PARTICIPANTS: We analyzed outcome data from 3400 newly diagnosed NMIBC patients from the Netherlands, the UK, Canada, and Spain. We generated genome-wide germline SNP data using Illumina OmniExpress and Infinium Global Screening Array in combination with genotype imputation.

OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Cohort-specific genome-wide association studies (GWASs) for RFS and PFS were performed using a Cox proportional hazard model. Results were combined in a fixed-effect inverse-variance weighted meta-analysis. Candidate genes for the identified SNP associations were prioritized using functional annotation, gene-based analysis, expression quantitative trait locus analysis, and transcription factor binding site databases. Tumor expression levels of prioritized genes were tested for association with RFS and PFS in an independent NMIBC cohort.

RESULTS AND LIMITATIONS: This meta-analysis revealed a genome-wide significant locus for RFS on chromosome 14 (lead SNP rs12885353, hazard ratio [HR] C vs T allele 1.55, 95% confidence interval [CI] 1.33-1.82, p = 4.0 10-8), containing genes G2E3 and SCFD1. Higher expression of SCFD1 was associated with increased RFS (HR 0.70, 95% CI 0.59-0.84, pFDR = 0.003). Twelve other loci were suggestively associated with RFS (p < 10-5), pointing toward 18 additional candidate genes. For PFS, ten loci showed suggestive evidence of association, indicating 36 candidate genes. Expression levels of ten of these genes were statistically significantly associated with PFS, of which four (IFT140, UBE2I, FAHD1, and NME3) showed directional consistency with our meta-analysis results and published literature.

CONCLUSIONS: In this first prognostic GWAS in NMIBC, we identified several novel candidate loci and five genes that showed convincing associations with recurrence or progression.

PATIENT SUMMARY: In this study, we searched for inherited DNA changes that affect the outcome of non-muscle-invasive bladder cancer (NMIBC). We identified several genes that are associated with disease recurrence and progression. The roles and mechanisms of these genes in NMIBC prognosis should be investigated in future studies.

PMID:34353775 | DOI:10.1016/j.euo.2021.07.001

See the original post here:
Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non-muscle-invasive Bladder Cancer - DocWire News

Posted in Genome | Comments Off on Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non-muscle-invasive Bladder Cancer – DocWire News

funded study discovers gene involved in male infertility – National Institutes of Health

Posted: at 8:47 am

Media Advisory

Thursday, August 5, 2021

Mutation in a single gene appears to account for a form of male infertility in which men fail to produce sperm, according to an international study funded in part by the National Institutes of Health. Males with the condition, known as non-obstructive azoospermia, fail to produce any sperm, even though they do not have any obstruction in the ducts through which sperm are released. The gene, PNLDC1, codes for an enzyme that processes a class of non-coding ribonucleic acids (RNA) so they can function. These non-coding RNAs are not involved in making proteins but are believed to be involved in various functions that occur during spermatogenesis the process by which cells in the testes produce sperm cells. The findings may provide insight into how sperm is produced and may one day lead to information helpful for the diagnosis and treatment of non-obstructive azoospermia. Similarly, greater understanding of the genes function may contribute to the development of new methods of male contraception.

The study was conducted by an international team of researchers and appears in The New England Journal of Medicine. Funding from NIHs Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) was provided to two authors institutions, the University of Utah School of Medicine, Salt Lake City (Kenneth I. Aston, Ph.D.) and Oregon Health and Science University, Portland (Donald F. Conrad, Ph.D.).

In the search for the genetic foundations of the condition, the researchers sequenced the exomes protein coding regions of the genome of 924 men with non-obstructive azoospermia. They found that four of the men had mutations in the PNLDC1 gene. Analysis of testicular tissue from the men showed that spermatagonia (sperm producing cells) failed to complete meiotic cell division and develop sperm cells. The authors theorized that other genes coding for enzymes involved in processing non-coding RNAs also might be involved in infertility due to azoospermia.

Stuart B. Moss, Ph.D., Health Scientist Administrator, NICHD Fertility and Infertility Branch, is available for comment.

Nagirnaja, L. Variant PNLDC1, Defective piRNA Processing, and Azoospermia. New England Journal of Medicine. 2021.

About the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): NICHD leads research and training to understand human development, improve reproductive health, enhance the lives of children and adolescents, and optimize abilities for all. For more information, visit https://www.nichd.nih.gov.

About the National Institutes of Health (NIH):NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

NIHTurning Discovery Into Health

###

Go here to read the rest:
funded study discovers gene involved in male infertility - National Institutes of Health

Posted in Gene Medicine | Comments Off on funded study discovers gene involved in male infertility – National Institutes of Health

Sarepta Therapeutics Executes Licensing Agreement for Gene Therapy Program from Nationwide Childrens Hospital to Treat Limb-Girdle Muscular Dystrophy…

Posted: at 8:47 am

Limb-girdle muscular dystrophy type 2A is the most common form of LGMD, accounting for a third of LGMD diagnoses

Sareptas unrivaled portfolio of investigational gene therapies for LGMD offers the potential to address six LGMD subtypes, which together represent more than 70% of all known LGMDs

CAMBRIDGE, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that upon completion of a number of preclinical and safety studies, it had executed an exclusive license agreement for an investigational gene therapy candidate, calpain 3 (CAPN-3), to treat Limb-girdle muscular dystrophy type 2A (LGMD2A), developed by the Abigail Wexner Research Institute at Nationwide Childrens Hospital (Nationwide Childrens).

LGMDs represent a group of distinct genetic neuromuscular diseases with a generally common set of symptoms, including progressive, debilitating weakness and wasting that begins in muscles around the hips and shoulders before progressing to muscles in the arms and legs. Many LGMD sub-types are significantly life-limiting and often life-ending diseases. Also known as calpainopathy, LGMD2A is caused by mutations in the CAPN-3 gene and is the most common type of LGMD, accounting for almost a third of cases.

Treatment plans for LGMD2A are currently limited to physical therapy, assistive devices and surgery for complications. Were excited about the opportunity to transform patient care for this significantly life-limiting disease by advancing the CAPN-3 program following extensive pre-clinical work by the team at Nationwide Childrens. Preclinical research conducted to date has provided early proof of concept for CAPN-3 in LGMD2A and supports further advancement, said Louise Rodino-Klapac, Sareptas executive vice president and chief scientific officer. We intend to build off the knowledge we have gained from our lead investigational gene transfer programs for Duchenne muscular dystrophy and LGMD2E, as the CAPN-3 program also uses the AAVrh74 vector to address another well-characterized genetic disease. Sareptas commitment and research investment in LGMD is unparalleled and we continue to work towards advancing all of our LGMD programs as quickly as possible.

Story continues

Like SRP-9001, Sareptas lead investigational gene transfer therapy for Duchenne muscular dystrophy, and the Companys five other LGMD programs, the LGMD2A program uses the AAVrh74 vector, designed to systematically and robustly deliver treatment to skeletal muscle, including the diaphragm, making it an ideal candidate to treat muscle disease.

The preclinical work on the CAPN-3 program in LGMD2A has been led by Zarife Sahenk, M.D., Ph.D., attending neurologist at Nationwide Childrens, Director of Clinical and Experimental Neuromuscular Pathology at The Research Institute at Nationwide Childrens and Professor of Pediatrics, Pathology and Neurology at The Ohio State University College of Medicine.

About Limb-girdle Muscular DystrophyLimb-girdle muscular dystrophies are genetic diseases that cause progressive, debilitating weakness and wasting that begins in muscles around the hips and shoulders before progressing to muscles in the arms and legs. Sareptas six LGMD gene therapy programs in development include LGMD2E, LGMD2D, LGMD2C, LGMD2B, LGMD2L and LGMD2A, which together represent more than 70 percent of known LGMD cases.

About Sarepta TherapeuticsSarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit http://www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.

Internet Posting of InformationWe routinely post information that may be important to investors in the 'For Investors' section of our website at http://www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.

Forward-Looking StatementsThis press release contains "forward-looking statements." Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "will," "intends," "potential," "possible" and similar expressions are intended to identify forward-looking statements. These forward-looking statements include statements regarding the potential benefits of the licensing agreement; the design of the AAVrh74 vector to systematically and robustly deliver treatment to skeletal muscle, including the diaphragm, making it an ideal candidate to treat muscle disease; the potential of our portfolio of investigational gene therapies for LGMD to address six LGMD subtypes, which together represent more than 70% of all known LGMDs; and our plan to continue to advance all of our LGMD programs as quickly as possible.

These forward-looking statements involve risks and uncertainties, many of which are beyond our control. Known risk factors include, among others: the expected benefits and opportunities related to the licensing agreement may not be realized or may take longer to realize than expected due to challenges and uncertainties inherent in product research and development. In particular, activities under the license may not result in any viable treatments suitable for commercialization due to a variety of reasons, including any inability of the parties to perform their commitments and obligations under the agreement; success in preclinical trials does not ensure that later clinical trials will be successful; Sarepta may not be able to execute on its business plans and goals, including meeting its expected or planned regulatory milestones and timelines, clinical development plans, and bringing its product candidates to market, due to a variety of reasons, many of which may be outside of Sareptas control, including possible limitations of company financial and other resources, manufacturing limitations that may not be anticipated or resolved for in a timely manner, regulatory, court or agency decisions, such as decisions by the United States Patent and Trademark Office with respect to patents that cover Sareptas product candidates and the COVID-19 pandemic; even if Sareptas programs result in new commercialized products, Sarepta may not achieve the expected revenues from the sale of such products; if the actual number of patients living with LGMD2A is smaller than estimated, Sareptas revenue and ability to achieve profitability may be adversely affected; and those risks identified under the heading Risk Factors in Sareptas most recent Annual Report on Form 10-K for the year ended December 31, 2020, and most recent Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (SEC) as well as other SEC filings made by the Company which you are encouraged to review.

Any of the foregoing risks could materially and adversely affect the Companys business, results of operations and the trading price of Sareptas common stock. For a detailed description of risks and uncertainties Sarepta faces, you are encouraged to review the SEC filings made by Sarepta. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. Sarepta does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof.

Source: Sarepta Therapeutics, Inc.

Investor Contact: Ian Estepan, 617-274-4052iestepan@sarepta.com

Media Contact: Tracy Sorrentino, 617-301-8566tsorrentino@sarepta.com

Read the original:
Sarepta Therapeutics Executes Licensing Agreement for Gene Therapy Program from Nationwide Childrens Hospital to Treat Limb-Girdle Muscular Dystrophy...

Posted in Gene Medicine | Comments Off on Sarepta Therapeutics Executes Licensing Agreement for Gene Therapy Program from Nationwide Childrens Hospital to Treat Limb-Girdle Muscular Dystrophy…

Page 839«..1020..838839840841..850860..»